ImmunityBio Inc. Common Stock vs Vishay Intertechnology Inc. Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $10.03 (market cap $10.51B), while Vishay Intertechnology Inc. Common Stock trades at $35.3 (market cap $5.30B). The key difference: ImmunityBio Inc. Common Stock is the larger of the two by market cap, and Vishay Intertechnology Inc. Common Stock pays a 1.16% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Vishay Intertechnology Inc. Common Stock for 0 Days on average.
| IBRX | VSH | |
|---|---|---|
Market Cap | $10.51B | $5.30B |
Volume | 10,445,785 | 3,213,272 |
Sector | Health | Technology |
52-Week High | $11.55 | $64.90 |
52-Week Low | $1.98 | $11.82 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.97B | $5.10B |
Dividend Yield | — | 1.16% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →Vishay Intertechnology manufactures discrete semiconductors and passive electronic components. Its products include diodes, MOSFETs, resistors, capacitors, and sensors.
Read more on VSH →